Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Waldenstrom Macroglobulinemia 1 Solitary Fibrous Tumor, Pleural 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Glioma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Clear Cell 1 Chondrosarcoma 1 Cancer Pain 1 Breast Neoplasms 1 Anemia 1 Anatomic Stage III Breast Cancer AJCC v8 1 Adult Patients Who Are Receiving Oncologic Care 1 Adjustment Disorders 1

Interventions

Temozolomide 43 Magnetic Resonance Spectroscopy 41 Radiotherapy 22 Specimen Handling 18 Biopsy 13 X-Rays 10 Radiation 10 trametinib 8 Bevacizumab 8 Nivolumab 7 Blood Specimen Collection 7 olaparib 6 fluorodopa F 18 6 dabrafenib 6 Radiotherapy, Intensity-Modulated 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 Lomustine 6 pembrolizumab 5 abemaciclib 5 Standard of Care 5 vorasidenib 4 ulixertinib 4 larotrectinib 4 ivosidenib 4 erdafitinib 4 Surgical Procedures, Operative 4 Dianhydrogalactitol 4 Cyclophosphamide 4 Aminolevulinic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Pharmacogenomic Testing × 1 year × Clear all

NCT01165333 2026-03-16

CILENT

Centre Oscar Lambret

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡